Clinical Trials

Differentiated Thyroid Cancer

NCT07450287 2026-03-04

CardioNETPOL

120 enrolled

Phase 2/3 Not yet recruiting

Carcinoid Heart Disease, Heart Failure, Heart Valve Diseases, Neuroendocrine Tumors, Serotonin Syndrome

NCT07440290 2026-02-27

DETERMINE

30 enrolled

CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT06941480 2026-02-19

A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

Phase 1 Not yet recruiting

12 enrolled

Phase 3 Not yet recruiting

Carcinoma, Neuroendocrine

NCT06822751 2026-02-17

FOMUTI

138 enrolled

Cystitis, Prostatitis, Urinary Tract Infections, Multiple Endocrine Neoplasia Type 1

NCT07376837 2026-01-29

PTC-RFA

30 enrolled

Thyroid Cancer, Papillary

NCT07373015 2026-01-28

Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm

EndocrineGastrointestinalNET

118 enrolled

Rectal Neuroendocrine Tumors

NCT07366658 2026-01-26

NEUK203-13

Phase 1 Not yet recruiting

9 enrolled

Phase 4 Not yet recruiting

Neuroendocrine Tumors

NCT07354698 2026-01-21

MHI

114 enrolled

Thyroid Cancer, Papillary

NCT07337447 2026-01-13

REWENEC 01

122 enrolled

Carcinoma, Neuroendocrine

NCT07316101 2026-01-05

Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery

20 enrolled

CNSEndocrine

Craniopharyngioma, Pituitary Neoplasms

NCT07102056 2025-12-29

18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms

152 enrolled

Neuroendocrine Tumors

NCT07274657 2025-12-10

SMILE

EndocrineGastrointestinalNETOther solid neoplasm

150 enrolled

Pancreas Adenocarcinoma (MSI-H)

NCT07258810 2025-12-02

ETP-NET

100 enrolled

Neoplasms, Neuroendocrine Tumors

NCT07200245 2025-10-01

HEMODYNAMICS

522 enrolled

Adrenal incidentaloma, Pheochromocytoma

NCT07192991 2025-09-25

NECTARINE

200 enrolled

Carcinoma, Neuroendocrine

NCT07156019 2025-09-04

Sintilimab in Combination With Surufatinib and Temozolomide in the Advanced Neuroendocrine Carcinoma

32 enrolled

Carcinoma, Neuroendocrine

NCT07141147 2025-09-03

A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery.

58 enrolled

Adrenocortical Carcinoma

NCT07138261 2025-08-22

TATC

100 enrolled

Thyroid Carcinoma, Anaplastic

NCT07042984 2025-06-29

RET-US

800 enrolled

Thyroid Cancer, Papillary, Lymphatic Metastasis, Thyroid Neoplasms

NCT07014254 2025-06-10

Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies

20 enrolled

Neuroendocrine Tumors

NCT06266949 2025-05-02

Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors

30 enrolled

Hemianopsia, Pituitary Neoplasms

NCT06951243 2025-04-30

A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer

40 enrolled

Advanced Extrapulmonary Neuroendocrine Cancer

NCT06901856 2025-03-30

Endoscopic Resection for Small Rectal Neuroendocrine Tumors

EndocrineGastrointestinalNET

120 enrolled

Rectal Neuroendocrine Tumor

NCT06899347 2025-03-27

PRO-COMAND

196 enrolled

Thyroid Cancer, Papillary

NCT06816394 2025-02-10

TAURUS

32 enrolled

Carcinoma, Neuroendocrine

NCT06804863 2025-02-03

Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer

600 enrolled

Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT06764368 2025-01-08

Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors

39 enrolled

Neuroendocrine Tumors

NCT06713304 2024-12-16

A Community-Based Intervention to Reduce Alcohol Use in Vietnamese Men

104 enrolled

Alcohol Drinking, Multiple Endocrine Neoplasia Type 1

NCT06701838 2024-12-03

OPTIMAL

15 enrolled

Cushing Syndrome, Pituitary Neoplasms, Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

NCT06607198 2024-09-23

PitNET2024

940 enrolled

Neoplasms, Pituitary Diseases, Neuroendocrine Tumors

NCT06556186 2024-08-15

Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma

600 enrolled

Pituitary Neoplasms

NCT06326853 2024-06-11

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

200 enrolled

EndocrineOther

Acromegaly, Cushing Syndrome, Endocrine System Diseases, Hypopituitarism, Obesity, Pituitary Neoplasms

NCT06408402 2024-05-10

PGLEXPO2

1,300 enrolled

CNSEndocrine

SDH-Related Familial Paraganglioma

NCT06344832 2024-04-03

SSTR PET/CT for Preoperative N Stage Evaluation in GEP-NETs

EndocrineGastrointestinalNET

40 enrolled

Gastro-entero-pancreatic Neuroendocrine Tumor

NCT04889742 2023-12-26

HETERERO

EndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

110 enrolled

Hyperthermia, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fever, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Neuroendocrine Tumors

NCT06156332 2023-12-05

A Study of Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy

EndocrineOther solid neoplasm

39 enrolled

Advanced Solid Tumors With Neuroendocrine Differentiation

NCT05894486 2023-06-08

Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors

40 enrolled

Neuroendocrine Tumors

NCT04788927 2023-04-07

PPGL-Pred